KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Change in Cash (2016 - 2026)

Abbott Laboratories' Change in Cash history spans 18 years, with the latest figure at -$1.7 billion for Q1 2026.

  • On a quarterly basis, Change in Cash fell 58.58% to -$1.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $271.0 million, a 9.27% increase, with the full-year FY2025 number at $906.0 million, up 25.83% from a year prior.
  • Change in Cash hit -$1.7 billion in Q1 2026 for Abbott Laboratories, down from $1.0 billion in the prior quarter.
  • Over the last five years, Change in Cash for ABT hit a ceiling of $1.3 billion in Q2 2022 and a floor of -$2.1 billion in Q1 2022.
  • Historically, Change in Cash has averaged -$176.2 million across 5 years, with a median of $187.0 million in 2023.
  • Biggest five-year swings in Change in Cash: tumbled 274.67% in 2022 and later surged 1643.1% in 2025.
  • Tracing ABT's Change in Cash over 5 years: stood at $288.0 million in 2022, then plummeted by 35.07% to $187.0 million in 2023, then tumbled by 68.98% to $58.0 million in 2024, then surged by 1643.1% to $1.0 billion in 2025, then plummeted by 270.03% to -$1.7 billion in 2026.
  • Business Quant data shows Change in Cash for ABT at -$1.7 billion in Q1 2026, $1.0 billion in Q4 2025, and $560.0 million in Q3 2025.